Full View

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study

J Davidson, T Pearlstein, P Londborg… - American Journal of …, 2001 - Am Psychiatric Assoc
OBJECTIVE: The study examined the efficacy of sertraline, compared with placebo, in
sustaining improvement and preventing relapse over 28 weeks in patients with …
被引用次数：342 相关文章

[引用][C] Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: Results of a 28-week double-blind, placebo-controlled study

J DAVIDSON - Am J. Psychiatry, 2001 - cir.nii.ac.jp
Efficacy of sertraline in preventing relapse of posttraumatic stress disorder : Results of a 28-week
double-blind, placebo-controlled study | CiNii Research CiNii 国立情報学研究所 学術情報 …

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study

J Davidson, T Pearlstein… - The American …, 2001 - pubmed.ncbi.nlm.nih.gov
Objective The study examined the efficacy of sertraline, compared with placebo, in
sustaining improvement and preventing relapse over 28 weeks in patients with …

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.

J Davidson, T Pearlstein, P Londborg… - The American Journal …, 2001 - europepmc.org
Objective The study examined the efficacy of sertraline, compared with placebo, in
sustaining improvement and preventing relapse over 28 weeks in patients with …

Efficacy of Sertraline in Preventing Relapse of Posttraumatic Stress Disorder: Results of a 28-Week Double-Blind, Placebo-Controlled Study

J Davidson, T Pearlstein, P Londborg, KT Brady… - …, 2003 - Am Psychiatric Assoc
Objective: The study examined the efficacy of sertraline, compared with placebo, in
sustaining improvement and preventing relapse over 28 weeks in patients with …
[PDF] academia.edu

[PDF][PDF] Efficacy of Sertraline in Preventing Relapse of Posttraumatic Stress Disorder: Results of a 28-Week Double-Blind, Placebo-Controlled Study

J Davidson, T Pearlstein, P Londborg, KT Brady… - Am J …, 2001 - academia.edu
Objective: The study examined the efficacy of sertraline, compared with placebo, in
sustaining improvement and preventing relapse over 28 weeks in patients with …
[PDF] researchgate.net

[PDF][PDF] Efficacy of Sertraline in Preventing Relapse of Posttraumatic Stress Disorder: Results of a 28-Week Double-Blind, Placebo-Controlled Study

J Davidson, T Pearlstein, P Londborg, KT Brady… - Am J …, 2001 - researchgate.net
Objective: The study examined the efficacy of sertraline, compared with placebo, in
sustaining improvement and preventing relapse over 28 weeks in patients with …

[引用][C] Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: Results of a 28-week double-blind, placebo-controlled study

J DAVIDSON, T PEARLSTEIN… - … American journal of …, 2001 - pascal-francis.inist.fr
Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: Results of a 28-week
double-blind, placebo-controlled study CNRS Inist Pascal-Francis CNRS Pascal and …

[引用][C] Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study

J Davidson, T Pearlstein, P Londborg - American Journal of Psychiatry, 2001 - elibrary.ru

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: Results of a 28-week double-blind, placebo-controlled study.

J Davidson, T Pearlstein, P Londborg… - The American Journal …, 2001 - psycnet.apa.org
Examined the efficacy of sertraline in sustaining improvement and preventing relapse over
28 wks in 21-69 yr olds with posttraumatic stress disorder (PTSD). 96 patients were …